Drawing for ONCOCOMPLETE

USPTO serial 97833340

ONCOCOMPLETE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
KERTGATE, AMY L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ONCOCOMPLETE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sana Hakim

Sana Hakim K&L GATES LLPP.O. BOX 1135CHICAGO, IL 60690United States

Goods and services

ClassDescriptionStatusFirst use
041Providing a website featuring resources, namely, non-downloadable videos and publications in the nature of newsletters and articles in the field of cancer; Providing an internet website portal featuring non-downloadable educational videos and webcasts in the field of cancerACTIVE—
042Platform as a service (PAAS) services featuring a computer software platform that allows patients to communicate with healthcare providers, doctors, and physicians, access on-demand phone support, and receive reminder phone calls, texts and emails in the field of cancer screening, pre-cancer screening, cancer diagnostic testing, disease or pre-disease detection, monitoring or surveillance; Providing temporary online use of non-downloadable software for use by physicians for use in collecting, requesting, managing, analyzing and comparing medical information, patient records, patient laboratory orders, patient tests and analysis; Providing an online website portal featuring technology that allows users to register and access the test results associated with medical and diagnostic test kits for detecting cancer; all of the foregoing for use in the field of cancer diagnostics, prognostics and treatment recommendationsACTIVE—
044Providing medical information to medical professionals and healthcare providers in the form of reports in the field of cancer screening, diagnostics, prognostics and treatment; Providing information to patients in the field of medical diagnostic screening; Providing medical information in the field of cancer awareness; Providing information in the field of prevention, screening, diagnosis, and treatment of cancer; Providing information to patients, medical professionals and healthcare providers in the field of medical diagnostic screening; Providing medical information; Providing a web site featuring medical information; Providing medical diagnostic services, namely, medical analysis services for diagnostic and treatment purposes provided by medical laboratories and medical diagnostic testing in the field of cancer; Providing genomic and genetic testing for medical purposes in the field of cancer; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer; Medical testing for diagnostic and prognostic purposes and therapy selection in the field of cancer and disease classification; Medical testing for diagnostic and treatment purposes in the field of cancer research and disease classification; Medical testing services, namely, genetic testing and next generation sequencing test for diagnosis and treatment of cancer featuring detection of genes and copy number variations for hereditary cancer, identification of hereditary risk associated with cancer and identification of predisposition to cancerACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Oct 1, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Oct 1, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 24, 2024EX1GSOU EXTENSION 1 GRANTED—
May 24, 2024EXT1SOU EXTENSION 1 FILED—
May 24, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 5, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 10, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 10, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 20, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 31, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 31, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Aug 31, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 31, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 31, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 25, 2023ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jul 11, 2023PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jun 22, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 22, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jun 22, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jun 22, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jun 22, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Jun 19, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 19, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 19, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2023DOCKASSIGNED TO EXAMINER—
Mar 31, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 14, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance